Citation: Ashara KC, Shah KV. Nuts and bolts of oil and temperature in topical preparations of salicylic acid.
Skin covers very much high area of the body and is the largest organ of the body and contains hair follicles, sweat ducts, too. As fatty acids and sweat are secreted from sebum, pH of skin is acidic in nature. The skin has multiple layers of cells which are divided into epidermis i.e. superfi cial layers and dermis i.e. deeper layers. Dermis is located below the epidermis and has multiple layers and contains large numbers of different structures. 1 Secondary cutaneous infection involvement is due to any bacterial, fungal, viral or parasitic agent. Skin diseases are a signifi cant problem all over the world. Fungal diseases in human are caused by inhalation of conidia, invasion of mucous membrane, contamination of wounds with candida or mycelia fragments, etc. 2 Topical fungal skin infections are dermatophytosis, ringworm, dandruff, athlete's foot, onychomycosis, candidiasis (yeast infections), aspergillosis, fusariosis. The success of fungal treatment in invasive fungal infections depends on how early in the course of infection that treatment has been instituted. Choice of treatment is based on several factors 3 . There are three major categories of antifungal drugs currently available for targeting different cell functions: the integrity of cell membrane, ergosterol biosynthesis, and integrity cell wall. 4 Chemically salicylic acid is 2-hydroxybenzoic acid (C 7 H 6 O 3 ). It has a molecular weight of 138 g/mol, melting point of 158-161°C. It is white or colorless, acicular crystals or a white, crystalline powder. It possesses the solubility of 2.48 mg/g in water and 625 mg/g in methanol. It has log p-value of 2.26. It belongs to BCS Class I. 10% w/w solution has pH of 2. Pka value is 2.97. 5 It is derived from the bark of Salix alba and leaves of wintergreen. It is synthetically manufactured too. It was extracted for the fi rst time by Buchner JA in early 19 th century. It possesses antimicrobial, keratolytic, analgesics (salicylates) actions. Moreover, it could be used for various categories such as moisturizing, skin, hair conditioner, etc. 6 The side effects of the salicylic acid include sensitivity, excessive drying, and irritation. (Registered brands in the Indian subcontinent pharmaceutical market) are coarse in texture and microscopic examination show crystals of salicylic acid. These tests confi rmed that 8-10% of salicylic acid is not completely solubilized in ointment base for keratolytic effect, so lesser penetration through stratum corneum. Traditional formulations of it in ointment bases have disadvantages of being greasy and irritant due to free crystals. 7 It softens the scaly layers of skin and eases their removal. It is applied to palms, soles, and scalp in concentrations of 2-10%. Salicylic acid is especially useful in combination with corticosteroids to enhance penetration and improve clinical effi cacy. 8 
MIC for
Candida albicans is very poor 8.9-22.33 mg/mL. 9
AIM
To explore the effect of oils, their ratio, and temperature for topical preparation of salicylic acid.
MATERIALS AND METHODS

MATERIALS
Salicylic acid was purchased from Sewa fine Chem. Ahmedabad, India. Parker Neem ® oil was purchased from Parker Biotech Pvt. Ltd. Chennai, India. Mogra oil, Black till oil, coconut oil, lemon oil, clove oil, lavender oil, heavy liquid paraffi n, light liquid paraffi n, and benzene were purchased from Astron Chemicals Ltd, Ahmedabad, India. Isopropyl myristate, turpentine oil, eucalyptus oil, olive oil, sesame oil, peppermint oil, oleic acid, mentha oil, bitter almond oil, isopropyl palmitate, methanol, and triacetin were purchased from Chem dye Corporation, Rajkot, India. Neem oil was gift sample from Green Well Biotech, Rajkot, India.
METHODS
SCANNING AND CALIBRATION CURVE OF SALICYLIC ACID
IN METHANOL
1 mg salicylic acid was taken, add methanol, carry out sonication by Sonicator (SUG-321, Remi Equipment Ltd, India) for 5 min, the volumes were made up to 100 ml with methanol in 100 mL volumetric fl ask (Borosil ® Pvt. Ltd). This was a stock solution (10 μg/mL) of salicylic acid. From it, different salicylic acid solutions were prepared in methanol, in the range of 10-25 μg/mL concentration and UV-scan was taken between wavelength ranges of 200-400 nm by the double beam UV-visible spectrometer (LT-2900, Labtronics (I) Pvt. Ltd, India). A wavelength at which solutions showed maximum absorbance was selected as absorbance maximum (λ max ) in nm for further analytical work. 10 The absorbance of these different solutions was measured at λ max . 11 The standard graph for salicylic acid was made by putting the concentration of salicylic acid (μg/mL) on X-axis and the average absorbance at λ max on the Y-axis (Microsoft Word ® , version Professional Plus 2010, Microsoft Corporation, Redmond, USA). 12 
SHORT-LISTING, SCREENING, AND OPTIMIZATION OF RATIO OF OILS MIXTURE
Among available oils, oils that had no interference of absorbance of salicylic acid were short-listed for screening purpose. If fewer absorbance in 200-400 nm were found, then that was checked by observing the absorbance of salicylic acid at λ max or not. Among the shortlisted oils, screening of oils was made on the basis of equilibrium solubility study. Salicylic acid was added in an excess amount in 5 mL of oil to be screened and then the mixture was stirred continuously for 1 h at 50 rpm and at ambient temperature in Orbital shaking incubator (1HB-164, Remi Equipment Ltd. India) following attainment of equilibrium. The mixtures were allowed to stand for one day at a side with occasional shaking. The mixtures were then allowed to shake for 15 min at 50 rpm and ambient temperature in the shaker bath. The obtained supernatant was fi ltered using fi lter paper of 11 μ pore size (Chem dye Corporation, Rajkot, India). Spectrophotometric measurement of the fi ltrate was measured at the λ max . Solubility study data were used for screening or selection of oils. 13 A mixture of oil was taken instead of single oil, so the ratio of oils was optimized by applying constrained simplex-centroid design and optimization was done within the interior of triangle region. One checkpoint batch was also carried out for validation of design. Applying Design ® Expert trial version 8.0.7.1 (State Ease Inc., MN, USA) optimized ratio was selected with maximum desirability and all the same parameters were also evaluated for optimized batch. 14, 15 Density: It was determined by 10 mL capacity specifi c gravity bottle of Borosil ® Pvt. Ltd. Organoleptic tests: Color, odor, and homogeneity of oils mixture were checked by organoleptic means.
pH: pH of oils mixture with 10% w/w of salicylic acid was very low, so check by indica ® (pH indicator paper, Merk specialties, Mumbai, India). 16 Compatibility study: Compatibility study was carried out by FTIR (Fourier Transform Infra-Red) spectroscopy analysis. A mixture of oils and salicylic acid were mixed geometrically and analyzed by FTIR-8400 spectrophotometer, Shimadzu, Japan in the scanning range of 400-4000 cm -1 and resolution 1 cm -1 too. 17 Statistical Analysis: Divide solubility data of salicylic acid in two groups. Group-I: solubility of salicylic acid at 70°C. Group-II: solubility of salicylic acid at 30°C. Calculate the variance of groups. Find the ratio of the variance of both groups. This is called F-value. Find the observed difference (SD) between means of two groups. Calculate standard error (SE) of difference between means of two groups. The ratio between SD and SE is unpaired student's t-test value. The signifi cance of F-value and t-value were found by referring to Microsoft Excel Worksheet ® , version Professional Plus 2010, Microsoft Corporation, Redmond, USA. All data were represented as mean of fi ve independent experiments ± Standard deviation (SD). All tests were performed at 5% level of signifi cance. 18 
RESULTS
Salicylic acid had wavelength maximum of 300 nm in methanol (Fig. 1) . Salicylic acid showed linearity in the range of 15-65 μg/mL in methanol at 300 nm wavelength maximum (Fig. 2) . Oils were screened out that had no absorbance in between 200-400 nm (Table 1) . From the solubility values of salicylic acid, oils presented in Table 2 , Parker Neem ® Oil (Antifungal oil), Isopropyl Myristate (Penetration enhancer oil), Mogra Oil (Solubility enhancer/ fl avoring oil) were selected for the prospective study. Using constrained simplex-centroid design different batches of oil mixtures were formulated (Table 3) and evaluated (Table 4) .
Salicylic acid-oils physical mixture (12 th Batch) exhibits (Fig. 3) Tabulated F-value at infi nite % level of significance is 1.96. Calculated F value of salicylic acid was very much lower than tabulated at infi nite %, therefore, it was insignifi cant and samples may very well be regarded as drawn from the same population, i.e. homogeneity of variances and z-test or t-test was carried out. Two independent samples of solubility at 30°C and 70°C with sample size were thirty so Student's unpaired t-test was carried out. Pooled degree of freedom (15+15-2) 28, tabulated t value at 5% level of signifi cance is 2.05. Calculated t value was higher than tabulated, p less than 0.05. It can occur less than 5 times in 100 i.e. rarely by chance. The difference was real in 95% experiments, hence highly signifi cant (t = 2.67, p less than 0.05 or signifi cant at 0.05%).
Batch 12 was selected with the maximum desirability of 0.391 and was considered for topical preparation. Formulation and evaluation of the 12 th batch were carried out for validation and % bias found to be satisfactory for the purpose of topical preparation.
DISCUSSION
Topical salicylic acid preparations like Betex Super cream ® , Betex ointment ® , Sapat malam ® , sapat plus malam ® etc. do not contain oil portion. The base of formulations is white soft paraffi n. This would not solubilize salicylic acid, therefore, lesser penetration through stratum corneum. Till date no any formulation is available in the market in which 10% w/w salicylic acid is solubilized in formulation with the infl uence of temperature and/or utilization of optimized ratio of oil mixture for the method of preparation. The study for the fi rst time provides technology to solubilize high amount of 10% w/w salicylic acid in the keratolytic formulation by means of the use of oils mixture and temperature. Oils also had their own properties like antifungal, penetration enhancer, etc. too. 18 FTIR study has confi rmed that salicylic acid is compatible with oil mixture. 19, 20 If salicylic acid is available as solubilized form, it will provide good penetration property, bioavailability followed by a better keratolytic effect. 7 Solubility at 30°C and at 70°C was the highest for the optimized (the 12 th ) batch. Statistical analysis has proved that all samples had the high solubility of salicylic acid at 70°C than that of 30°C. 
CONCLUSION
Selected oil combinations (Batch 12) for salicylic acid had the highest solubility of salicylic acid at 30°C and 70°C temperature too. Elevation of temperature to solubilize salicylic acid is more effective technology. This oils ratio (Batch 12) could be selected for topical preparation of salicylic acid like cream, ointment etc. This leads to solving the problem of solubility of salicylic acid. Oil portion provides more penetration through stratum corneum as compared to hydrophilic phase. It acts as the chemical penetration enhancer and temporarily breakdown lipid-protein and protein-protein bond of skin structure.
LIMITATIONS
The study was limited to less number of oils used for short listing and screening purpose.
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